Q9NQR9 (G6PC2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 87.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Glucose-6-phosphatase 2 Short name=G-6-Pase 2 Short name=G6Pase 2 EC=3.1.3.9 Alternative name(s): Islet-specific glucose-6-phosphatase catalytic subunit-related protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 355 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May hydrolyze glucose-6-phosphate to glucose in the endoplasmic reticulum. May be responsible for glucose production through glycogenolysis and gluconeogenesis By similarity. |
| Catalytic activity | D-glucose 6-phosphate + H2O = D-glucose + phosphate. Ref.8 |
| Pathway | |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein Ref.7. |
| Tissue specificity | Specifically expressed in pancreas and also detected to a lower extent in testis. Expressed by most islet cells in the pancreas (at protein level). Ref.1 |
| Post-translational modification | N-glycosylated; the non-glycosylated form is more unstable and is degraded through the proteasome. Ref.7 |
| Polymorphism | Genetic variations in G6PC2 define the fasting plasma glucose levels quantitative trait locus 1 (FGQTL1) [MIM:612108]. The normal fasting plasma glucose level in the plasma is defined as less than 100 mg per deciliter (5.55 mmol per liter). Higher fasting plasma glucose levels predict type 2 diabetes in young adults and increases the risk of mortality. |
| Sequence similarities | Belongs to the glucose-6-phosphatase family. |
| Biophysicochemical properties | Kinetic parameters: KM=0.45 mM for glucose-6-phosphate (at pH 6.5) |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NQR9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NQR9-2) The sequence of this isoform differs from the canonical sequence as follows: 74-102: ILFGHRPYWWVQETQIYPNHSSPCLEQFP → KSIWPCNGRILCLVCHGNRCPEPHCLWDG 103-355: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q9NQR9-3) The sequence of this isoform differs from the canonical sequence as follows: 148-154: LTWSFLW → HAGGRGL 155-355: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 355 | 355 | Glucose-6-phosphatase 2 | PRO_0000334509 | |||||
Regions | |||||||||
| Topological domain | 1 – 24 | 24 | Lumenal Potential | ||||||
| Transmembrane | 25 – 45 | 21 | Helical; Potential | ||||||
| Topological domain | 46 – 56 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 57 – 77 | 21 | Helical; Potential | ||||||
| Topological domain | 78 – 115 | 38 | Lumenal Potential | ||||||
| Transmembrane | 116 – 136 | 21 | Helical; Potential | ||||||
| Topological domain | 137 – 146 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 147 – 167 | 21 | Helical; Potential | ||||||
| Topological domain | 168 | 1 | Lumenal Potential | ||||||
| Transmembrane | 169 – 189 | 21 | Helical; Potential | ||||||
| Topological domain | 190 – 211 | 22 | Cytoplasmic Potential | ||||||
| Transmembrane | 212 – 232 | 21 | Helical; Potential | ||||||
| Topological domain | 233 – 261 | 29 | Lumenal Potential | ||||||
| Transmembrane | 262 – 282 | 21 | Helical; Potential | ||||||
| Topological domain | 283 – 293 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 294 – 314 | 21 | Helical; Potential | ||||||
| Topological domain | 315 – 318 | 4 | Lumenal Potential | ||||||
| Transmembrane | 319 – 339 | 21 | Helical; Potential | ||||||
| Topological domain | 340 – 355 | 16 | Cytoplasmic Potential | ||||||
| Motif | 352 – 355 | 4 | Prevents secretion from ER Potential | ||||||
Sites | |||||||||
| Active site | 115 | 1 | Proton donor Potential | ||||||
| Active site | 174 | 1 | Nucleophile By similarity | ||||||
| Binding site | 79 | 1 | Substrate Potential | ||||||
| Binding site | 168 | 1 | Substrate Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 92 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||
Natural variations | |||||||||
| Alternative sequence | 74 – 102 | 29 | ILFGH…LEQFP → KSIWPCNGRILCLVCHGNRC PEPHCLWDG in isoform 2. | VSP_033648 | |||||
| Alternative sequence | 103 – 355 | 253 | Missing in isoform 2. | VSP_033649 | |||||
| Alternative sequence | 148 – 154 | 7 | LTWSFLW → HAGGRGL in isoform 3. | VSP_046180 | |||||
| Alternative sequence | 155 – 355 | 201 | Missing in isoform 3. | VSP_046181 | |||||
| Natural variant | 171 | 1 | I → V. Corresponds to variant rs2232322 [ dbSNP | Ensembl ]. | VAR_043372 | |||||
| Natural variant | 207 | 1 | Y → S. Corresponds to variant rs2232323 [ dbSNP | Ensembl ]. | VAR_043373 | |||||
| Natural variant | 219 | 1 | V → L. Corresponds to variant rs492594 [ dbSNP | Ensembl ]. | VAR_043374 | |||||
| Natural variant | 324 | 1 | S → P. Corresponds to variant rs2232326 [ dbSNP | Ensembl ]. | VAR_043375 | |||||
| Natural variant | 340 | 1 | P → L. Corresponds to variant rs2232327 [ dbSNP | Ensembl ]. | VAR_043376 | |||||
| Natural variant | 342 | 1 | S → C. Corresponds to variant rs2232328 [ dbSNP | Ensembl ]. | VAR_043377 | |||||
Experimental info | |||||||||
| Mutagenesis | 50 | 1 | N → A: No effect on N-glycosylation. Ref.7 | ||||||
| Mutagenesis | 92 | 1 | N → A: Loss of N-glycosylation. Ref.7 | ||||||
| Mutagenesis | 287 | 1 | N → A: No effect on N-glycosylation. Ref.7 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes." Martin C.C., Bischof L.J., Bergman B., Hornbuckle L.A., Hilliker C., Frigeri C., Wahl D., Svitek C.A., Wong R., Goldman J.K., Oeser J.K., Lepretre F., Froguel P., O'Brien R.M., Hutton J.C. J. Biol. Chem. 276:25197-25207(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], CHARACTERIZATION, TISSUE SPECIFICITY. |
| [2] | "Endocrine pancreas consortium." Melton D., Brown J., Kenty G., Permutt A., Lee C., Kaestner K., Lemishka I., Scearce M., Brestelli J., Gradwohl G., Clifton S., Hillier L., Marra M., Pape D., Wylie T., Martin J., Blistain A., Schmitt A. Bowers Y.Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Pancreas. |
| [3] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Retina. |
| [4] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Cerebellum. |
| [7] | "The islet-specific glucose-6-phosphatase-related protein, implicated in diabetes, is a glycoprotein embedded in the endoplasmic reticulum membrane." Shieh J.-J., Pan C.-J., Mansfield B.C., Chou J.Y. FEBS Lett. 562:160-164(2004) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TOPOLOGY, MUTAGENESIS OF ASN-50; ASN-92 AND ASN-287, GLYCOSYLATION AT ASN-92. |
| [8] | "Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP)." Petrolonis A.J., Yang Q., Tummino P.J., Fish S.M., Prack A.E., Jain S., Parsons T.F., Li P., Dales N.A., Ge L., Langston S.P., Schuller A.G.P., An W.F., Tartaglia L.A., Chen H., Hong S.-B. J. Biol. Chem. 279:13976-13983(2004) [PubMed] [Europe PMC] [Abstract] Cited for: CATALYTIC ACTIVITY. |
| [9] | "Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas." Dogra R.S., Vaidyanathan P., Prabakar K.R., Marshall K.E., Hutton J.C., Pugliese A. Diabetologia 49:953-957(2006) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE SPLICING. |
| [10] | "A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels." Bouatia-Naji N., Rocheleau G., Van Lommel L., Lemaire K., Schuit F., Cavalcanti-Proenca C., Marchand M., Hartikainen A.-L., Sovio U., De Graeve F., Rung J., Vaxillaire M., Tichet J., Marre M., Balkau B., Weill J., Elliott P., Jarvelin M.-R. Froguel P.Science 320:1085-1088(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN FGQTL1. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF283835 Genomic DNA. Translation: AAF82810.1. BQ777188 mRNA. No translation available. CR627438 mRNA. Translation: CAH10524.1. AC069137 Genomic DNA. No translation available. CH471058 Genomic DNA. Translation: EAX11291.1. BC104778 mRNA. Translation: AAI04779.1. BC113376 mRNA. Translation: AAI13377.1. |
| IPI | IPI00028155. IPI00465025. IPI00830064. |
| RefSeq | NP_001075155.1. NM_001081686.1. NP_066999.1. NM_021176.2. |
| UniGene | Hs.283963. |
3D structure databases | |
| ProteinModelPortal | Q9NQR9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000364512. |
Polymorphism databases | |
| DMDM | 74725272. |
Proteomic databases | |
| PaxDb | Q9NQR9. |
| PRIDE | Q9NQR9. |
Protocols and materials databases | |
| DNASU | 57818. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000282075; ENSP00000282075; ENSG00000152254. ENST00000375363; ENSP00000364512; ENSG00000152254. ENST00000429379; ENSP00000396939; ENSG00000152254. ENST00000571993; ENSP00000460909; ENSG00000262563. ENST00000572378; ENSP00000459575; ENSG00000262563. ENST00000573192; ENSP00000461775; ENSG00000262563. |
| GeneID | 57818. |
| KEGG | hsa:57818. |
| UCSC | uc002uem.3. human. uc002uen.3. human. |
Organism-specific databases | |
| CTD | 57818. |
| GeneCards | GC02P169757. |
| HGNC | HGNC:28906. G6PC2. |
| MIM | 608058. gene. 612108. phenotype. |
| neXtProt | NX_Q9NQR9. |
| PharmGKB | PA134944773. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG82628. |
| HOGENOM | HOG000264239. |
| HOVERGEN | HBG003560. |
| InParanoid | Q9NQR9. |
| KO | K01084. |
| OMA | DWIHIDT. |
| OrthoDB | EOG402WSH. |
| PhylomeDB | Q9NQR9. |
Enzyme and pathway databases | |
| BioCyc | MetaCyc:HS14422-MONOMER. |
| Reactome | REACT_111217. Metabolism. REACT_15518. Transmembrane transport of small molecules. |
| UniPathway | UPA00138. |
Gene expression databases | |
| ArrayExpress | Q9NQR9. |
| Bgee | Q9NQR9. |
| CleanEx | HS_G6PC2. |
| Genevestigator | Q9NQR9. |
Family and domain databases | |
| Gene3D | 1.20.144.10. 1 hit. |
| InterPro | IPR016275. Glucose-6-phosphatase. IPR016118. P_Acid_Pase/Cl_peroxidase_N. IPR000326. P_Acid_Pase_2/haloperoxidase. [Graphical view] |
| Pfam | PF01569. PAP2. 1 hit. [Graphical view] |
| PIRSF | PIRSF000905. Glucose-6-phosphatase. 1 hit. |
| SMART | SM00014. acidPPc. 1 hit. [Graphical view] |
| SUPFAM | SSF48317. AcPase_VanPerase. 1 hit. |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 57818. |
| NextBio | 64766. |
| SOURCE | Search... |
Entry information
| Entry name | G6PC2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NQR9 Secondary accession number(s): E9PAX2, Q6AHZ0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
